title: "Cross talk" between the bioactive glycerolipids and sphingolipids in signal transduction.
abstract: Hydrolysis of phosphatidylcholine via receptor-mediated stimulation of phospholipase D produces phosphatidate that can be converted to lysophosphatidate and diacylglycerol. Diacylglycerol is an activator of protein kinase C, whereas phosphatidate and lysophosphatidate stimulate tyrosine kinases and activate the Ras-Raf-mitogen-activated protein kinase pathway. These three lipids can stimulate cell division. Conversely, activation of sphingomyelinase by agonists (e.g., tumor necrosis factor-alpha) causes ceramide production that inhibits cell division and produces apoptosis. If ceramides are metabolized to sphingosine and sphingosine 1-phosphate, then these lipids can stimulate phospholipase D and are also mitogenic. By contrast, ceramides inhibit the activation of phospholipase D by decreasing its interaction with the G-proteins, ARF and Rho, which are necessary for its activation. In whole cells, ceramides also stimulate the degradation of phosphatidate, lysophosphatidate, ceramide 1-phosphate, and sphingosine 1-phosphate through a multifunctional phosphohydrolase (the Mg(2+)-independent phosphatidate phosphohydrolase), whereas sphingosine inhibits phosphatidate phosphohydrolase. Tumor necrosis factor-alpha causes insulin resistance, which may be partly explained by ceramide production. Cell-permeable ceramides decrease insulin-stimulated glucose uptake in 3T3-L1 adipocytes after 2-24 h, whereas they stimulate basal glucose uptake. These effects do not depend on decreased tyrosine phosphorylation of the insulin receptor and insulin receptor substrate-1 or the interaction of insulin receptor substrate-1 with phosphatidylinositol 3-kinase. They appear to rely on the differential effects of ceramides on the translocation of GLUT1-and GLUT4-containing vesicles. It is concluded that there is a significant interaction and "cross-talk" between the sphingolipid and glycerolipid pathways that modifies signal transduction to control vesicle movement, cell division, and cell death.
authors.affiliation: Signal Transduction Laboratories, Faculty of Medicine, University of Alberta, Edmonton, Canada.
authors.forename: D N
authors.initials: DN
authors.lastname: Brindley
authors.forename: A
authors.initials: A
authors.lastname: Abousalham
authors.forename: Y
authors.initials: Y
authors.lastname: Kikuchi
authors.forename: C N
authors.initials: CN
authors.lastname: Wang
authors.forename: D W
authors.initials: DW
authors.lastname: Waggoner
mesh_terms: D000818:Animals; D016923:Cell Death; D002455:Cell Division; D002518:Ceramides / Q000378:metabolism / Q000494:pharmacology; D005994:Glycerophosphates / Q000378:metabolism*; D006801:Humans; D007333:Insulin Resistance; D010711:Phosphatidate Phosphatase / Q000378:metabolism; D010739:Phospholipase D / Q000378:metabolism; D015290:Second Messenger Systems; D015398:Signal Transduction; D013107:Sphingolipids / Q000378:metabolism*; D013108:Sphingomyelin Phosphodiesterase / Q000378:metabolism
chemical_list: D002518:Ceramides; D005994:Glycerophosphates; D013107:Sphingolipids; D010711:Phosphatidate Phosphatase; D013108:Sphingomyelin Phosphodiesterase; D010739:Phospholipase D